BVF PARTNERS L P/IL Insider Trading $CRXX EPIRUS Biopharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BVF PARTNERS L P/IL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BVF PARTNERS L P/IL. BVF PARTNERS L P/IL is 10% Owner in LIGAND PHARMACEUTICALS INC ($LGND) and 10% Owner in AVIGEN INC \DE ($AVGN) and 10% Owner in NEUROCRINE BIOSCIENCES INC ($NBIX) and 10% Owner in ARQULE INC ($ARQL) and 10% Owner in CURIS INC ($CRIS) and 10% Owner in DYNAVAX TECHNOLOGIES CORP ($DVAX) and 10% Owner in EPIRUS Biopharmaceuticals, Inc. ($CRXX).
BVF PARTNERS L P/IL in EPIRUS Biopharmaceuticals, Inc.
Trading Symbol: CRXXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 10,008,871 shares
Latest Transaction: Dec 09 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of BVF PARTNERS L P/IL in EPIRUS Biopharmaceuticals, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARQL, AVGN, CRIS, DVAX, CRXX, LGND, NBIX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 09 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.57 | 28,000 | 15,960 | 10,008,871 | 10 M to 10 M (+0.28 %) |
Dec 09 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.57 | 8,000 | 4,560 | 9,980,871 | 10 M to 10 M (+0.08 %) |
Dec 09 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.57 | 11,000 | 6,270 | 9,972,871 | 10 M to 10 M (+0.11 %) |
Dec 09 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.57 | 3,000 | 1,709 | 9,961,871 | 10 M to 10 M (+0.03 %) |
Dec 09 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.57 | 1,000 | 570 | 9,958,871 | 10 M to 10 M (+0.01 %) |
Dec 09 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.57 | 1,700 | 969 | 9,957,871 | 10 M to 10 M (+0.02 %) |
Dec 09 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.57 | 878,000 | 500,460 | 9,956,171 | 9.1 M to 10 M (+9.67 %) |
Dec 09 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.57 | 245,000 | 139,650 | 9,078,171 | 8.8 M to 9.1 M (+2.77 %) |
Dec 09 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.57 | 354,872 | 202,277 | 8,833,171 | 8.5 M to 8.8 M (+4.19 %) |
Dec 05 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.55 | 6,000 | 3,300 | 8,478,299 | 8.5 M to 8.5 M (+0.07 %) |
Dec 05 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.55 | 2,000 | 1,100 | 8,472,299 | 8.5 M to 8.5 M (+0.02 %) |
Dec 05 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.55 | 2,300 | 1,265 | 8,470,299 | 8.5 M to 8.5 M (+0.03 %) |
Dec 05 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.54 | 8,000 | 4,308 | 8,467,999 | 8.5 M to 8.5 M (+0.09 %) |
Dec 05 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.54 | 2,000 | 1,077 | 8,459,999 | 8.5 M to 8.5 M (+0.02 %) |
Dec 05 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.54 | 3,400 | 1,831 | 8,457,999 | 8.5 M to 8.5 M (+0.04 %) |
Dec 03 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.55 | 6,000 | 3,279 | 8,454,599 | 8.4 M to 8.5 M (+0.07 %) |
Dec 03 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.55 | 2,000 | 1,093 | 8,448,599 | 8.4 M to 8.4 M (+0.02 %) |
Dec 03 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.55 | 1,800 | 984 | 8,446,599 | 8.4 M to 8.4 M (+0.02 %) |
Dec 03 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.55 | 16,000 | 8,800 | 8,444,799 | 8.4 M to 8.4 M (+0.19 %) |
Dec 03 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.55 | 4,000 | 2,200 | 8,428,799 | 8.4 M to 8.4 M (+0.05 %) |
Dec 03 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.55 | 6,800 | 3,740 | 8,424,799 | 8.4 M to 8.4 M (+0.08 %) |
Dec 01 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.49 | 4,000 | 1,976 | 8,417,999 | 8.4 M to 8.4 M (+0.05 %) |
Dec 01 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.49 | 1,000 | 494 | 8,413,999 | 8.4 M to 8.4 M (+0.01 %) |
Dec 01 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.49 | 1,600 | 790 | 8,412,999 | 8.4 M to 8.4 M (+0.02 %) |
Nov 26 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.47 | 7,000 | 3,275 | 8,411,399 | 8.4 M to 8.4 M (+0.08 %) |
Nov 26 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.47 | 2,000 | 936 | 8,404,399 | 8.4 M to 8.4 M (+0.02 %) |
Nov 26 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.47 | 3,300 | 1,544 | 8,402,399 | 8.4 M to 8.4 M (+0.04 %) |
Nov 25 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.45 | 49,000 | 22,050 | 8,399,099 | 8.4 M to 8.4 M (+0.59 %) |
Nov 25 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.45 | 14,000 | 6,300 | 8,350,099 | 8.3 M to 8.4 M (+0.17 %) |
Nov 25 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.45 | 20,100 | 9,045 | 8,336,099 | 8.3 M to 8.3 M (+0.24 %) |
Nov 25 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.45 | 7,000 | 3,150 | 8,315,999 | 8.3 M to 8.3 M (+0.08 %) |
Nov 25 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.45 | 2,000 | 900 | 8,308,999 | 8.3 M to 8.3 M (+0.02 %) |
Nov 25 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.45 | 3,000 | 1,350 | 8,306,999 | 8.3 M to 8.3 M (+0.04 %) |
Nov 18 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.60 | 6,000 | 3,578 | 8,303,999 | 8.3 M to 8.3 M (+0.07 %) |
Nov 18 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.60 | 2,000 | 1,193 | 8,297,999 | 8.3 M to 8.3 M (+0.02 %) |
Nov 18 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.60 | 1,200 | 716 | 8,295,999 | 8.3 M to 8.3 M (+0.01 %) |
Nov 14 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.60 | 6,000 | 3,600 | 8,294,799 | 8.3 M to 8.3 M (+0.07 %) |
Nov 14 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.60 | 2,000 | 1,200 | 8,288,799 | 8.3 M to 8.3 M (+0.02 %) |
Nov 14 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.60 | 1,000 | 600 | 8,286,799 | 8.3 M to 8.3 M (+0.01 %) |
Nov 14 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.60 | 2,000 | 1,200 | 8,285,799 | 8.3 M to 8.3 M (+0.02 %) |
Nov 14 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.60 | 1,000 | 600 | 8,283,799 | 8.3 M to 8.3 M (+0.01 %) |
Nov 14 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.60 | 600 | 360 | 8,282,799 | 8.3 M to 8.3 M (+0.01 %) |
Nov 12 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.60 | 83,000 | 49,659 | 8,282,199 | 8.2 M to 8.3 M (+1.01 %) |
Nov 12 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.60 | 23,000 | 13,761 | 8,199,199 | 8.2 M to 8.2 M (+0.28 %) |
Nov 12 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.60 | 33,100 | 19,804 | 8,176,199 | 8.1 M to 8.2 M (+0.41 %) |
Nov 12 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.58 | 8,000 | 4,640 | 8,143,099 | 8.1 M to 8.1 M (+0.10 %) |
Nov 12 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.58 | 2,000 | 1,160 | 8,135,099 | 8.1 M to 8.1 M (+0.02 %) |
Nov 12 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.58 | 4,000 | 2,320 | 8,133,099 | 8.1 M to 8.1 M (+0.05 %) |
Nov 12 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.58 | 65,000 | 37,486 | 8,129,099 | 8.1 M to 8.1 M (+0.81 %) |
Nov 12 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.58 | 18,000 | 10,381 | 8,064,099 | 8 M to 8.1 M (+0.22 %) |
Nov 12 2008 | CRXX | EPIRUS Biopharmace ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.58 | 26,700 | 15,398 | 8,046,099 | 8 M to 8 M (+0.33 %) |
Page: 1